Dispensing of substitute drug products by pharmacists — notification of substitution.
Effective Oct 20, 2020Sept. 10, 1976, D.C. Law 1-81, title III, § 301; as added Mar. 11, 2010, D.C. Law 18-118, § 2(d), 57 DCR 901; Oct. 20, 2020, D.C. Law 23-133, § 2(e)
- (a) An individual shall be notified of a drug substitution, including an interchangeable biological product, and provided the right to refuse the substitution prior to purchase of the substitute drug product.
(b)
- (1) The Department of Health shall create and distribute to all pharmacies signs that state in block letters not less than one inch in height: “This pharmacy may substitute a less expensive drug product that is equivalent to the one prescribed by your health care practitioner unless you request otherwise.
- (2) Each pharmacy shall display the sign in a prominent place that has a clear and unobstructed public view at or near the place where prescriptions are dispensed.
History
Sept. 10, 1976, D.C. Law 1-81, title III, § 301
as added Mar. 11, 2010, D.C. Law 18-118, § 2(d), 57 DCR 901
Oct. 20, 2020, D.C. Law 23-133, § 2(e)